PASG
Passage BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.58
+2.29%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$2.43
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$2.44
- EPS estimate
- -$2.44
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -17.5%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$2.44 | -$2.44 | In line | — |
| May 12, 2026 | -$2.15 | -$2.36 | Miss -9.77% | — |
| Mar 3, 2026 | -$2.19 | -$4.08 | Miss -86.30% | — |
| Aug 12, 2025 | -$4.00 | -$2.96 | Beat 26.00% | — |
| Mar 4, 2025 | -$0.21 | -$0.20 | Beat 4.76% | — |
| Nov 13, 2024 | -$0.23 | -$0.31 | Miss -34.78% | — |
| Aug 8, 2024 | -$0.31 | -$0.26 | Beat 16.13% | — |
| Mar 4, 2024 | -$0.41 | -$0.30 | Beat 26.83% | $5.9M |
| Nov 13, 2023 | -$0.47 | -$0.49 | Miss -4.26% | — |
| May 11, 2023 | -$0.49 | -$0.63 | Miss -28.57% | — |
| Mar 6, 2023 | -$0.48 | -$0.50 | Miss -4.17% | — |
| Nov 10, 2022 | -$0.75 | -$0.49 | Beat 34.67% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026